Aimed Alliance Urges Senators to Expand Access to Treatments for OUD
On November 2, 2022, Aimed Alliance hosted a legislative briefing on facilitating access to medications…
Author Aimed Alliance
FDA Issues Warning to CBD Manufacturer
The U.S. Food and Drug Administration (FDA) has issued a warning letter to a company…
Upcoming Webinar: Essential Health Benefits, Importation, and More – Do You Know the Risks?
Join Aimed Alliance for a Free HR.com Webinar: Essential Health Benefits, Importation, and More –…
Upcoming Webinar: Cannabis, CBD, and Cannabinoids: What Employers and Consumers Should Know
Join Aimed Alliance for a Free Advocacy Briefing on Cannabis, CBD, and Cannabinoids: What Employers…
Aimed Alliance Releases Updated Open Enrollment Brochures
The open enrollment periods for individual, small, large group, and Medicare plans have recently opened…
Upcoming Advocacy Briefing: S.3257 Facilitating Access to MOUD Treatments
Join Aimed Alliance for a Free Advocacy Briefing on S.3257 to Facilitate Access to Medication…
Upcoming HR.com Webinar: Cannabis, CBD, and Cannabinoids: What Employers and Consumers Should Know
Join Aimed Alliance for a Free Webinar on Cannabis, CBD, and Cannabinoids: What Employers and…
Aimed Alliance and AfPA host HR.com Webinar on Health Benefits: The Hidden Cost of “Cost-Saving Programs”
On Oct. 20, 2022, Aimed Alliance and the Alliance for Patient Access hosted a webinar…
Aimed Alliance Comments On Section 1557 Proposed Rule
On October 3, 2022, Aimed Alliance submitted a comment to the Department of Health and…
OIG Releases Report on Opioid Use Disorders in Medicare Part D Beneficiaries
Recently, the Department of Health and Human Services, Office of Inspector General (OIG) released a…